See also this year's filing and all EDGAR filings for this company.
PDF Report 0000891293_2022_CTI_Biopharma_CORP.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0000891293, CTI Biopharma CORP
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 68,379,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 176,000 |
| 3 | remainder_Assets | 3,879,000 |
| 4 | LiabilitiesCurrent | 66,651,000 |
| 5 | LiabilitiesNoncurrent | 2,016,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 75,989,060 |
| 9 | ResearchAndDevelopmentExpense | 44,685,495 |
| 10 | remainder_Expenses | 1,257,703 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -2,691,188 |
| 13 | remainder_ComprehensiveNetIncome | -1,210 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 72,434,000 |
| 1 | Liabilities | 68,667,000 |
| 2 | Expenses | 121,932,258 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 3,767,000 |
| 5 | NetIncome | -124,623,446 |
| 6 | ComprehensiveNetIncome | -124,624,051 |
| 7 | BaseVar | 132,862,828 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.65 |
| 9 | EconomicCapitalRatio | 1.13 |
Edgar->Model Mapping
Feature Distribution
Change over Time
